Pioneering the Future of Drug Discovery: Insights from XtalPi’s International Symposium XtalPi recently held its 2026 International Symposium, showcasing innovative AI techniques in molecular glue drug discovery, featuring expert insights worldwide.

Pioneering the Future of Drug Discovery: Insights from XtalPi’s International Symposium #China #Shanghai #AI_Drug_Discovery #XtalPi #molecular_glue

Magnet Biomedicine Appoints Nick Vlahakis as New Chief Medical Officer to Drive Clinical Development Magnet Biomedicine has appointed Dr. Nick Vlahakis as Chief Medical Officer to advance its clinical development strategy and molecular glue therapeutics pipeline.

Magnet Biomedicine Appoints Nick Vlahakis as New Chief Medical Officer to Drive Clinical Development #USA #Boston #molecular_glue #Magnet_Biomedicine #Nick_Vlahakis

Magnet Biomedicine and Lilly Join Forces for Innovative Molecular Glue Therapies Magnet Biomedicine announces a strategic collaboration with Lilly to develop groundbreaking molecular glue medicines for oncology, enhancing therapeutic options.

Magnet Biomedicine and Lilly Join Forces for Innovative Molecular Glue Therapies #USA #Boston #Lilly #molecular_glue #Magnet_Biomedicine

AbbVie and Neomorph Collaborate on Innovative Molecular Glue for Cancer and Immune Disorders AbbVie and Neomorph have entered a licensing agreement to develop molecular glue degraders targeting cancer and immune disorders, promising groundbreaking treatments.

AbbVie and Neomorph Collaborate on Innovative Molecular Glue for Cancer and Immune Disorders #United_States #AbbVie #North_Chicago #Neomorph #molecular_glue